No analyst-consensus coverage for this name (US-listed names are crawled on a rolling cycle; foreign listings have no coverage).
For our own independent read, see Fair Value (FV) — a model, not a Street target — and the analyst scorecard (RATE) for how ranked analysts stack up.
